Randomised clinical trial: comparison of tegoprazan and placebo in non-erosive reflux disease.

Seung Han KimKwang Bum ChoHoon Jai ChunSang Woo LeeJoong Goo KwonDong Ho LeeSang Gyun Kim Hwoon Yong JungJi Won KimJoon Seong LeeHyojin ParkSuck Chei ChoiSam Ryong JeeHyun-Soo KimKwang Hyun KoSeun Ja ParkYong Chan LeeSoo-Heon ParkAh Rong KimEun Ji KimHyun Wook ParkBong Tae KimGeun Seog Song

Published in: Alimentary pharmacology & therapeutics (2021)

Tegoprazan 50 and 100 mg showed superior therapeutic efficacy compared with the placebo, as well as a favourable safety profile in patients with NERD. Registration number: ClinicalTrials.gov identifier NCT02556021.

Keyphrases

double blind
clinical trial
phase iii
placebo controlled
open label
phase ii
study protocol
clinical evaluation